EFFECT OF EBV AND HHV-6 LATENT INFECTION OR REACTIVATION ON MS ACTIVITY: A PROSPECTIVE CLINICAL COHORT STUDY
Funder
National Health and Medical Research Council
Funding Amount
$263,845.00
Summary
Multiple Sclerosis (MS) is a severely debilitating neurodegenerative disease, affecting over 16,000 Australians. There is a need to examine which factors drive the progression of this disease. We examine the role of two viral infections on MS activity. It has the potential to contribute to antiviral interventions that might prevent relapses and-or decrease the clinical progression of this debilitating disease.